SU

Steve Usdin

Person

Heard in 1 episode across 1 show since Oct 2026

Steve Usdin is a journalist and the Washington Editor at BioCentury, where he covers biotechnology policy and related developments. He is known for reporting on the intersection of government, science, and the biotechnology industry.

Episodes

1
across 1 show

First heard

Oct 2026

Guest appearances

1

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data
MonthEpisodes
Nov 20250
Dec 20250
Jan 20260
Feb 20260
Mar 20260
Apr 20260
May 20260
Jun 20260
Jul 20260
Aug 20260
Sep 20260
Oct 20261

What Steve Usdin has said on podcasts

11 statements

  1. on U.S.-China biotech co-development dealsNegativeOct 6, 2026· BioCentury This Week

    More large biotech co-development deals may produce more restrictive Treasury rules.

    “that's likely to fuel a more restrictive rules when we do see Treasury putting out its rules on how it's going to incorporate biotech into coins.”

    Listen at 7:40

    Open the episode · Ep. 391 - China deals, Beam lawsuit, MFN models, Nobel winners
  2. on Beam Therapeutics lawsuit against YoltecNeutralOct 6, 2026· BioCentury This Week

    Beam Therapeutics filed a trade-secret lawsuit against Yoltec.

    “Beam Therapeutics filed suit on September 25 in the U.S. District Court for the District of Massachusetts.”

    Listen at 11:49

    Open the episode · Ep. 391 - China deals, Beam lawsuit, MFN models, Nobel winners
  3. on Beam-Yoltec trade-secret trialNeutralOct 6, 2026· BioCentury This Week

    A trial outcome would depend heavily on explaining complex science to jurors.

    “the outcome of a trial, again, if it does go to trial, is going to hinge a lot on the two sides' ability to make very complex scientific information accessible to jurors.”

    Listen at 15:24

    Open the episode · Ep. 391 - China deals, Beam lawsuit, MFN models, Nobel winners
See all 11 statements →

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

1 episode featuring Steve Usdin, newest first